Candesartan

Résumé du livre

Drugs in Context is an independent, peer reviewed and practice orientated review of all the significant data on a specific drug, placed in the context of the disease and clinical practice setting. Candesartan; Disease Overview: Lowering elevated blood pressure reduces morbidity from stroke, MI, congestive heart failure and renal failure, and recent outcomes studies have demonstrated that antihypertensive agents offer clinical benefits beyond their blood pressure lowering efficacy. Drug Review: All candesartan doses were shown to be more effective than placebo in terms of controlling systolic (SBP) and diastolic blood pressure (DBP). placebo or candesartan. Improving Practice: The new GMS contract, published in 2003, is an important step towards the development of primary care in the UK. Of the 550 clinical points available in the GMS contract, 129 relate directly to hypertension.